Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/27/2024 10:52:21 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 1237
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68981
IPIX was already working on a simple capsule (not
(3)
petemantx
03/16/2021 9:52:15 AM
68978
Very interesting. This is opposite of what I have
Zadie
03/16/2021 8:55:03 AM
68975
Excellent! Successful covid trial could very well
(4)
williamsc
03/14/2021 8:33:59 PM
68973
You are correct. I was associating IBD
thefamilyman
03/14/2021 12:13:42 PM
68971
https://pbs.twimg.com/media/Es2Tky_XAAEHx6U?forma
(7)
AlanC
03/14/2021 11:15:43 AM
68969
That PR confirms my point.The large intestine
(6)
Kelt
03/14/2021 9:43:24 AM
68968
Tune up for 3/19 rule change? Wash trades have
(5)
AlanC
03/14/2021 9:40:33 AM
68967
@ Kelt - I sent you a PM thinking I did not have
(9)
thefamilyman
03/13/2021 10:59:43 PM
68966
Do you think the volume of 775K (less than 1/3 of
DrTim
03/13/2021 10:50:21 PM
68965
If I recall,oral B for IBD /Crohns was designed
(9)
Kelt
03/13/2021 9:44:03 PM
68964
It would be like Nitroglycerin; blowing up the
(1)
gchgch
03/13/2021 8:56:31 PM
68963
Possibly use under the tongue as a direct route
(1)
williamsc
03/13/2021 5:26:52 PM
68960
Seems that the effectiveness of the drug
(3)
bandg
03/13/2021 2:53:51 PM
68959
More hearings 3/17 with SEC and DTCC under fire
(6)
AlanC
03/13/2021 2:17:00 PM
68957
I heard Dr. Fauci on TV yesterday indicating that
Chemdeps
03/13/2021 1:55:24 PM
68954
My definition now of a good week is how many new
(3)
petemantx
03/12/2021 4:50:14 PM
68951
Volume is very low so far today. Just under
(5)
Drano
03/12/2021 1:24:18 PM
68949
I've asked the administrator. When I get a
(3)
someconcerns
03/12/2021 12:23:47 PM
68947
Does anyone know what just happened to IHangout?
gchgch
03/12/2021 11:22:52 AM
68945
Below are several Drug SI's for Covid-19
(8)
farrell
03/10/2021 11:19:05 PM
68944
I have been trying to answer the same question
(1)
crashco
03/10/2021 9:25:28 PM
68943
In lookin for Selectivity Indexes to compare
(1)
Boneysteak
03/10/2021 9:18:14 PM
68942
Machine Learning Model: Where are candidates
(6)
crashco
03/10/2021 7:17:49 PM
68940
No matter where Brilacidin stands in the study,
(8)
petemantx
03/10/2021 3:50:14 PM
68939
As I stated, not an exhaustive or complete
(1)
crashco
03/10/2021 3:32:44 PM
68938
Solid work! Thank you. Seems like Ritonavir is
(4)
Ultimate
03/10/2021 3:29:38 PM
68937
clinicaltrial.gov Search criteria: Indication
(4)
crashco
03/10/2021 3:22:39 PM
68934
Yaaa I know and will still be vigilant in staying
NotRichYet2
03/10/2021 9:23:38 AM
68933
I see our resident idiot has been watching Full
(1)
scgmck1
03/10/2021 8:59:41 AM
68931
Thanks! I love to see third party votes of
(6)
Ultimate
03/10/2021 8:01:59 AM
68930
$IPIX ICYMI
(3)
TonyCorvette
03/10/2021 7:47:40 AM
68929
Brilacidin found to have a high theoretical viral
(3)
kerdom
03/10/2021 7:42:39 AM
68928
Attached is an article regarding the
(6)
petemantx
03/09/2021 6:01:52 PM
68927
Today I got my first of two vaccine shots
NotRichYet2
03/09/2021 4:10:44 PM
68926
I hope that you are right. But since the DTCC is
(2)
thefamilyman
03/09/2021 2:30:19 PM
68925
I thought that this was a proposed rule change
(1)
thefamilyman
03/09/2021 1:55:21 PM
68923
Correct DTCC IS TRYING to cover its arse as is
(9)
AlanC
03/09/2021 10:51:02 AM
68922
I would encourage everyone to watch the YouTube
(5)
DrTim
03/09/2021 10:11:01 AM
68920
I am going to break my own rule just this one
(13)
Mo
03/08/2021 10:43:40 PM
68919
Love it. GME has them by the short hairs. Fun to
(7)
AlanC
03/08/2021 7:38:09 PM
68917
Here is a you tube video my son sent me this
(3)
falcon74
03/08/2021 2:49:43 PM
68916
Just saw Fauci on TV explaining how they are now
(4)
Chemdeps
03/08/2021 11:44:44 AM
68915
SI-426
(1)
crashco
03/08/2021 11:02:37 AM
68914
Brilacidin has a history of success in human
(4)
mtnman213
03/08/2021 9:29:25 AM
68913
This is big news and imho will cause those that
(5)
AlanC
03/08/2021 8:11:22 AM
68912
Clinical Trials Site Updated. Added site, Russia
(2)
crashco
03/08/2021 6:38:24 AM
68911
This week's clinical trial failures for
(12)
Drano
03/07/2021 6:40:58 PM
68908
Since the PR came out Friday mid-day, it is
(8)
Chemdeps
03/07/2021 3:25:59 PM
68906
Good point. I still think that even if BARDA is
(9)
Ultimate
03/06/2021 1:04:02 PM
68903
Let's not forget that the BARDA grant program for
(5)
Drano
03/06/2021 11:25:14 AM
< Previous
Next >
Recent Articles
Introducing a New Seasonal Flavor from Harvest Snaps!
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target
Equashield® Earns Top Workplaces 2024 Recognition for Excellence
Growth Forecast: Mainframe Spending and Cloud Strategies Explored
Cloudelligent Secures AWS Migration Competency Recognition
Heitman LLC Expands Logistics Footprint with New Acquisition
Deutsche Bank Lowers Boeing Price Target, Retains Buy Rating
Larry Mazza Launches Exclusive Sports Betting Membership Site
Glean and Algorithia Join Forces to Transform AI Workflows
Onconetix Secures $2 Million Funding to Boost Oncology Innovations
Dun & Bradstreet Prepares for Q3 Earnings and Investor Events
Join Acclaimed Medium James Van Praagh for Spirit Messages
Agora Unveils Innovative Voice-Driven AI SDK with OpenAI
Manatt Expands Health Care Team with Expert Richard Cho
Vanguard Presents Innovative Battery Options at Major Industry Event
Oshkosh Corporation Expands Electric Fleet with New Order
Alexander Group Launches Groundbreaking Research Initiative
Maya Kaimal Unveils Unique Chili Crisp at Whole Foods Market
Riot Platforms Reports Impressive Bitcoin Production Growth
Kemper Auto Mural Project Brings Community Art to Miami
Celebrating a Century: The MILKY WAY® Journey through Time
Principle Recruiting Welcomes Nicole Kennedy as New Principal
60 Degrees Pharmaceuticals Launches ARAKODA Education Initiative
Thesis* Welcomes Katherine Snow as New Legal Leader
Ripple and Mercado Bitcoin Join Forces to Revolutionize Payments
Citi Raises Carvana Price Target Amid Impressive Sales Projections
Understanding Oil's Impact on Inflation and Central Banks
Cambria Partners with ETF Architect to Transform Tax Efficiency
Uber Partners with Avride to Enhance Food Deliveries and Rides
Wavin Launches New Production Facility to Boost Water Solutions
Constellation Brands Surges with Strong Beer Demand Results
Hansard Global PLC Innovates with Majesco LifePlus Solutions
EVgo Inc Soars with Conditional Loan Guarantee and Upgrade
Godspeed Capital Expands ICE USA with RGC&A Partnership
Berkshire Hathaway Adjusts Portfolio, Sells Bank of America Shares
Counterpart Enhances Insurance Offerings with New GL Insurance
UBS Analysts Predict Challenges Ahead for Biogen Inc. Stock
Legal Action Unfolds: Class Action Against BioLab for Toxic Spill
Lennar Corporation's Promising Future in Home Construction
Tetra Tech Secures Massive USACE Environmental Services Deal
Outdoor Living Supply Enhances Portfolio with Latest Acquisition
Birdzi Partners with Armeta Analytics to Streamline Integrations
Mercer's New Study Highlights Paid Leave Trends for Employers
Consumer Behavior Shift Revealed in RRD Survey Insights
Exploring the Yacht Club de Monaco's Commitment to Sustainability
Riveron Recognized as Top Place to Work in Chicago's Market
Empowering Lives: Insights from the Dialysis at Home Summit
University of Rochester Introduces Cutting-Edge AI Master's Program
Navient's Commitment to Caregivers Earns Major Recognition
Baker Tilly's Strategic Move: Welcoming Alirrium for Enhanced Automation